202 related articles for article (PubMed ID: 21969663)
41. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
42. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
44. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
Willatt JM; Hussain HK; Adusumilli S; Marrero JA
Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
[TBL] [Abstract][Full Text] [Related]
45. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
[TBL] [Abstract][Full Text] [Related]
46. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
[TBL] [Abstract][Full Text] [Related]
47. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
48. Prediction of growth rate of solid renal masses: utility of MR imaging features--preliminary experience.
Dodelzon K; Mussi TC; Babb JS; Taneja SS; Rosenkrantz AB
Radiology; 2012 Mar; 262(3):884-93. PubMed ID: 22267588
[TBL] [Abstract][Full Text] [Related]
49. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
50. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
[TBL] [Abstract][Full Text] [Related]
51. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
van den Bos IC; Hussain SM; Dwarkasing RS; Hop WC; Zondervan PE; de Man RA; IJzermans JN; Walker CW; Krestin GP
J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956
[TBL] [Abstract][Full Text] [Related]
52. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
Compagnon P; Grandadam S; Lorho R; Turlin B; Camus C; Jianrong Y; Lainé F; Meunier B; Deugnier Y; Boudjema K
Transplantation; 2008 Oct; 86(8):1068-76. PubMed ID: 18946344
[TBL] [Abstract][Full Text] [Related]
53. MRI findings of rapidly progressive hepatocellular carcinoma.
Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
[TBL] [Abstract][Full Text] [Related]
54. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
55. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
56. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases.
Kondo H; Kanematsu M; Itoh K; Ito K; Maetani Y; Goshima S; Matsuo M; Matsunaga N; Konishi J; Hoshi H; Moriyama N
Magn Reson Imaging; 2005 Jan; 23(1):89-95. PubMed ID: 15733793
[TBL] [Abstract][Full Text] [Related]
57. Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Pastor CM
Radiology; 2010 Nov; 257(2):589. PubMed ID: 20959554
[No Abstract] [Full Text] [Related]
58. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.
Petersein J; Spinazzi A; Giovagnoni A; Soyer P; Terrier F; Lencioni R; Bartolozzi C; Grazioli L; Chiesa A; Manfredi R; Marano P; Van Persijn Van Meerten EL; Bloem JL; Petre C; Marchal G; Greco A; McNamara MT; Heuck A; Reiser M; Laniado M; Claussen C; Daldrup HE; Rummeny E; Kirchin MA; Pirovano G; Hamm B
Radiology; 2000 Jun; 215(3):727-36. PubMed ID: 10831691
[TBL] [Abstract][Full Text] [Related]
59. The Diagnostic Performance of Dynamic Contrast-enhanced MR Imaging for Detection of Small Hepatocellular Carcinoma Measuring Up to 2 cm: A Meta-Analysis.
Kierans AS; Kang SK; Rosenkrantz AB
Radiology; 2016 Jan; 278(1):82-94. PubMed ID: 26098460
[TBL] [Abstract][Full Text] [Related]
60. Is dynamic gadolinium enhancement needed in MR imaging for the preoperative assessment of scaphoidal viability in patients with scaphoid nonunion?
Donati OF; Zanetti M; Nagy L; Bode B; Schweizer A; Pfirrmann CW
Radiology; 2011 Sep; 260(3):808-16. PubMed ID: 21712471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
